Gregory Krieg

The media and voters don't always see eye-to-eye on the results of high-stakes political debates. But following Wednesday night's CNBC-moderated showdown in Boulder, Colorado, there seems to be a rare consensus, at least on the question of how…

It's been called the worst job in American politics. When first floated as a replacement for outgoing House Speaker John Boehner a couple weeks ago, Rep. Paul Ryan (R-Wisc.) dismissed it out of hand. The post was seen as a professional dead end. The…

Florida Sen. Marco Rubio took a serious swipe at Democratic front-runner Hillary Clinton on Wednesday night during the third Republican primary debate. Calling the mainstream media a "super PAC" dedicated to protecting liberals, Rubio told the CNBC…

Former Florida Gov. Jeb Bush lectured his former pupil Sen. Marco Rubio (Fla.) during a tense exchange at the third Republican debate on CNBC over Rubio's recent absences from a series of votes in the Senate.  On Wednesday, the editorial board of…

Outgoing House Speaker John Boehner can finally pack his bags.  After weeks spent trying to find a replacement, the Republican conference in the House of Representatives voted on Wednesday to nominate Rep. Paul Ryan (Wisc.) to succeed Boehner, who…

The stage will be crowded again, but the race for the Republican presidential nomination is narrowing as the candidates gather for the third debate of this tumultuous 2016 primary campaign on Wednesday night in Boulder, Colorado. For the first time,…

After four months of nearly uninterrupted dominance of the Republican primary field, Donald Trump is losing his edge and, according to a new poll, his lead among GOP voters.  But like so much else in this oddball race, the candidate poised to topple…

As Donald Trump tells it, his bravest journey hasn't been from the penthouse to whiffing distance of the White House, but in bringing the family business from Queens and Brooklyn, New York City's two largest boroughs, to gilded Manhattan.  "It's not…

The young pharmaceutical CEO who purchased a little-known generic drug used primarily by AIDS and cancer patients, then spiked its retail price by 5,000% — only to see another company waltz in on Thursday to undersell him and undermine his big…